Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.70 -2.56%
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
SFNC, CSBR, MAN, More
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
SFNC, CSBR, MAN, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
- State Street (STT) Tops Q2 EPS by 33c, Beats on Revenue
- Piper Sandler on Progressive Corp. (PGR): 'Peak Results Fears Are Overblown'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
